Nu Skin Enterprises Stock (NYSE:NUS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$7.57

52W Range

$6.72 - $24.38

50D Avg

$9.81

200D Avg

$13.52

Market Cap

$380.22M

Avg Vol (3M)

$852.12K

Beta

1.13

Div Yield

$0.24 (2.35%)

NUS Company Profile


Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Show More

Industry

Household & Personal Products

Sector

Consumer Defensive

Exchange

NYSE

ADR

-

Country

US

Employees

3,700

IPO Date

Nov 22, 1996

Website

NUS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Rhyz Other Segment$35.21M--
Manufacturing Segment$181.40M--
Nu Skin$1.75B--
Other Product Lines-$163.61M$190.46M
Wellness-$992.34M$1.06B
Beauty-$1.07B$1.44B
Devices and Related Consumables--$658.00M

Fiscal year ends in Dec 23 | Currency in USD

NUS Financial Summary


Dec 23Dec 22Dec 21
Revenue$1.97B$2.23B$2.70B
Operating Income$48.27M$110.85M$233.99M
Net Income$8.60M$104.78M$147.27M
EBITDA$48.27M$207.84M$337.73M
Basic EPS$0.17$2.10$2.93
Diluted EPS$0.17$2.07$2.86

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 08, 24 | 11:25 PM
Q1 24May 08, 24 | 12:00 AM
Q4 23Feb 14, 24 | 6:40 PM

Peer Comparison


TickerCompany
USNAUSANA Health Sciences, Inc.
HLFHerbalife Nutrition Ltd.
PIIPolaris Inc.
FLOFlowers Foods, Inc.
IPARInter Parfums, Inc.